Description

Ganoderma lucidum intracellular polysaccharides are extracted from deep-cultivated fungal mycelia and have demonstrated immunomodulatory, hepatoprotective, and anti-cancer effects in preclinical models of chronic hepatitis and hepatic carcinoma .
These capsules are ideal for research into innate immunity enhancement, liver protection assays, and cancer adjunctive studies. Formulated as commercial-grade capsules for easy dosing and reproducibility in experimental settings.

Product Specifications

Yunzhi Intracellular Polysaccharide Mechanism of Action

Yunzhi intracellular polysaccharides have shown to:

1. Stimulate macrophage and T?cell activity, boosting immunity in elderly and infection models

2. Protect liver cells against oxidative and toxin-induced damage

3. Exhibit potential anti-tumor effects through immune system support

Yunzhi Intracellular Polysaccharide Research Applications

• Chronic hepatitis models (virus- or toxin-engineered)

• HCC (liver cancer) adjunct studies

• Immunosenescence and immune function optimization research

• Anti-inflammatory and antioxidant assays in hepatic systems

Yunzhi Intracellular Polysaccharide Safety & Handling

• Intended for laboratory research only, not for clinical or veterinary administration

• Expected to be generally safe; monitor for gustatory or digestive sensitivity as observed in typical use

• Store sealed with standard lab PPE; discard if capsules degrade

Core Keywords

Yunzhi polysaccharide capsules, Ganoderma lucidum intracellular polysaccharide, reishi mushroom capsules, H50020929, hepatoprotection research, immune modulation compound, Peking University pharma polysaccharide

Research Use Disclaimer

This product is strictly for laboratory and preclinical research use. Not approved for therapeutic, clinical, diagnostic, or veterinary use. Misuse may involve health or regulatory risks. Always follow institutional protocols.